Health intervention in at-risk groups and territories begins this Wednesday in the capital's municipalities of Regla, Guanabacoa, Habana del Este and San Miguel del Padrón with the anti-COVID-19 vaccine candidate Abdala, developed by the Center for Genetic Engineering and Biotechnology (CIGB).

 The certainty that the Abdala vaccine candidate is very safe was ratified on Tuesday afternoon by Dr. Marta Ayala Avila, general director of the Center for Genetic Engineering and Biotechnology (CIGB), in a new working meeting convened by the country's top leadership with experts and scientists who in the course of all these months have contributed directly to the confrontation with the COVID-19.

It is normal for viruses to mutate, as it is a phenomenon related to the transmission itself, because as they reproduce there are errors that cause changes in the genetic sequence and give rise to mutations.

The Center for Research and Rehabilitation of Hereditary Ataxias (CIRAH by its Spanish acronym), is one of the health institutions in the province of Holguin(eastern Cuba), affected by the economic, commercial and financial blockade of the United States against Cuba.

Cuba studied 18,417 samples for COVID 19, resulting in 1,071 positive ones. The country accumulates 3, 879,873 samples taken and 118,168 positive.

Miguel Diaz-Canel Bermudez, first secretary of the Cuban communist party and president of the Republic, underlined today the importance of achieving well-planned and assured vaccination strategies in each territory.

Specialized care for patients with lupus is one of the priorities of the Cuban health system in the fight against this harmful disease, Doctor of Science Gil Alberto Reyes Llerena, president of the Cuban Society of Rheumatology, told the Cuban News Agency.

Cuba studied 24,111 samples for COVID 19, resulting in 1,116 positive ones. The country accumulates 3, 861,456 samples taken and 117,097 positive.

 Dr. Francisco Duran Garcia, national director of epidemiology of the ministry of public health (MINSAP by its Spanish acronym), reiterated today in Havana that the increase of patients in ICUs throughout the country, and the increase of pediatric cases of COVID-19, show how risky the epidemiological situation is in Cuba.

Cuba will undertake a population interventional study with its COVID-19 candidate vaccines in large vulnerable groups of people and territories after having administered 415 doses in different phases of clinical trials.

In recent weeks, SARS-CoV-2, the coronavirus that causes COVID-19, has had a more aggressive, virulent behavior, towards complications and severity and more lethal with the circulation of new strains, said today in Havana Francisco Duran, national director of epidemiology of the ministry of public health ( MINSAP by its Spanish acronym).

The resident representative in Cuba of the United Nations Development Program (UNDP), Maribel Gutierrez, reported on Twitter that the island is making progress in the preparation of a new Funding Request to access the Global Fund COVID-19 Response Mechanism (C19RM).

Cuba studied 23,282 samples for COVID 19, resulting in 1,162 positive ones. The country accumulates 3, 787,896 samples taken and 113,876 positive.

Cuban President Miguel Díaz-Canel Bermúdez congratulated today on Twitter the rector of the University of Havana (UH), Dr. Miriam Nicado, awarded Wednesday with the Cuban Academy of Sciences (ACC) Honorary Scholar distinction.